Speech-Language Pathologists in Ilion, NY Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Ashley Hoffman, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 41 W River St, Ilion, NY 13357 Phone: 315-717-6503 |
Miss Deavon Elizabeth Eysaman, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 405 Tulip Dr, Ilion, NY 13357 Phone: 315-542-1449 |
Ms. Melinda Mary Marley, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 118 W Rand St, Ilion, NY 13357 Phone: 315-894-2707 |
Mrs. Katherine M. Brien, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 116 West St, Ilion, NY 13357 Phone: 315-895-0320 |
News Archive
New research may open door to novel therapies for treating immune disorders
A new research discovery published in the April 2014 issue of the Journal of Leukocyte Biology may open the door to new therapies that help treat immune disorders or curb runaway inflammation. Specifically, scientists have discovered a molecule that can induce cell death (apoptosis) in a key type of immune cell (dendritic cells).
Natural blood ingredient prevents HIV
Scientists in Germany scientists say they have discovered a natural ingredient in human blood that prevents the HIV-1 virus from infecting immune cells.
Tampa, Florida-based medical institution purchases Streamline Health's document workflow solutions
Streamline Health Solutions, Inc. a leading provider of document workflow solutions for hospitals, today announced that a leading Tampa, Florida-based medical institution has purchased three additional workflow licenses to expand the use of Streamline Health's document workflow solutions to help optimize business processes across the enterprise and improve operational efficiencies. Streamline Health expects at least two of the workflow solutions to be fully implemented and operational prior to the conclusion of the current fiscal year.
Researchers confirm new drug development route for treating multiple sclerosis, asthma
Brazilian researchers who study a native venomous fish have confirmed a route to drug development for the treatment of chronic inflammatory diseases such as multiple sclerosis and asthma.
Large-scale network to test potential treatments in muscular dystrophy
Some 35 neuromuscular disease experts, along with biotechnology and government representatives, will meet Friday and Saturday at the Westin La Paloma here to develop a large-scale network to test potential treatments in muscular dystrophy
› Verified 2 days ago
Physical Therapists
Optometrists
Speech-Language Pathologists
Occupational Therapists
Chiropractors